Compression Wound Sock With Silver Nanoparticles for Chronic Ulcers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic venous and diabetic leg ulcers, including compression therapy and silver dressings, fail to improve healing rates and are often ineffective due to elevated MMP-9 levels, bacterial biofilms, and chronic inflammatory mediators, leading to high socioeconomic costs and recurrent ulcers.
Innovation Solution
A sock made with silver nanoparticle shapes, natural wicking fibers like wool and alpaca, and elastic fibers that directly downregulate MMP-9, kill bacteria protected by biofilms, and promote wound healing through graduated compression and antibacterial, anti-inflammatory, and angiogenic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If compression therapy and silver dressings are used for treating chronic venous and diabetic ulcers, then wound coverage and basic care are provided, but healing rates do not improve and ulcers remain unhealed after 12 weeks
Solution Approach 1:
The patent changes the chemical and physical parameters of the wound environment by introducing silver nanoparticles that specifically target and reduce MMP-9 protease activity. The nanoparticles alter the biochemical composition of the wound bed, converting a chronic non-healing state into an acute-like healing state by modifying protease levels and promoting a favorable cytokine environment.
Solution Approach 2:
The invention uses a composite material system combining silver nanoparticles with natural wicking fibers (wool, alpaca) and elastic fibers. This composite structure provides multiple functions: compression therapy, moisture wicking, silver nanoparticle delivery, and mechanical support, all integrated into a single wearable sock that addresses multiple wound healing parameters simultaneously.
2Object-generated harmful factors
If MMP-9 levels are elevated in chronic wounds, then proteases continue to destroy wound matrix, but standard treatments do not reduce MMP-9 levels
Solution Approach 1:
The patent converts the harmful effect of elevated MMP-9 protease activity into a beneficial outcome by using silver nanoparticles to specifically target and reduce these proteases. The nanoparticles transform the chronic wound environment with excessive matrix destruction into a controlled environment where protease activity is balanced, allowing wound matrix to accumulate and heal rather than being continuously degraded.
3Object-affected harmful factors
If bacterial biofilms are present in chronic wounds, then bacteria are protected from immune system and antibiotics, but current silver dressings do not penetrate or eliminate the biofilm
Solution Approach 1:
The silver nanoparticles act as an intermediary agent that can penetrate bacterial biofilms and deliver antimicrobial action directly to protected bacteria. The nanoparticles serve as a mediator between the external treatment and the previously inaccessible bacterial colonies, enabling elimination of biofilm-protected pathogens without requiring the bacteria to be exposed to traditional antibiotics or immune system cells.
4Quantity of substance
If natural wicking fibers like wool and alpaca are used in the sock, then absorption and wicking of exudate and necrotic tissue is improved, but manufacturing complexity increases
Solution Approach 1:
The natural fiber components serve multiple functions simultaneously: they provide moisture wicking, exudate absorption, cushioning, and a substrate for silver nanoparticle attachment. This multi-functionality reduces the need for separate components and simplifies the overall structure, as the natural fibers fulfill several wound care requirements that would otherwise require additional materials or features.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Improved Sock increases circulation, reduces bacterial and inflammatory loads, suppresses MMP-9, and stimulates healing, demonstrating improved wound care with increased patient compliance and reduced healthcare costs by providing a wearable, durable, and effective treatment option.
Implementation Method 1
The use of silver nanoparticles has proven to have antibacterial, antifungal and antiviral properties
Implementation Method 2
The yarns, including wool and alpaca fibers, will be a substantial proportion of the inside of the sock, so as to be in direct contact with the skin and wound. The Improved Sock provides cushion, absorption and wicking of exudate and necrotic tissue from the leg and foot.
Implementation Method 3
Medical compression socks are known to increase the circulation in the feet and legs
Implementation Method 4
elastic fibers composed into a yarn knitted to make the sock
Implementation Method 5
The Improved Sock directly down regulates the MMP-9 and bacterial proteases
Implementation Method 6
The specific AgNP shapes which have shown improved antibacterial, anti-inflammatory, and angiogenic properties
Data Source
AI summary
The Improved Sock is made of yarns knitted into a foot and calf, with graduated compression on an individual's foot from the foot to the calf. The yarns can include wool and alpaca fibers. A substantial proportion of wool and/or alpaca are on the inside of the sock so as to be in direct contact with the skin and wound. The Improved Sock provides absorption and wicking of inflammatory mediators, bacteria and biofilm and necrotic exudate from the foot and leg. The Improved Sock has AgNP shapes electrostatically bonded to the yarn. At least 30% of the mass of the AgNP shapes attached to the fibers have a shape selected from the group consisting of truncated triangular plates (a triangle with the corners rounded off), triangular prisms, discs and combinations of two or more of them. The Improved Sock functions as a unique wound dressing with the sock in direct contact with the wound.